Stang A, Becker JC, Nghiem P, Ferlay J. The association between geographic location and incidence of Merkel cell carcinoma in comparison to melanoma: an international assessment. Eur J Cancer. 2018;94:47–60.

Article  PubMed  PubMed Central  Google Scholar 

Jacobs D, Huang H, Olino K, Weiss S, Kluger H, Judson BL, Zhang Y. Assessment of age, period, and birth cohort effects and trends in Merkel cell carcinoma incidence in the United States. JAMA Dermatol. 2021;157(1):59–65.

Article  PubMed  Google Scholar 

Paulson KG, Nghiem P. One in a hundred million: Merkel cell carcinoma in pediatric and young adult patients is rare but more likely to present at advanced stages based on US registry data. J Am Acad Dermatol. 2019;80(6):1758–60.

Article  PubMed  Google Scholar 

Agelli M, Clegg LX. Epidemiology of primary Merkel cell carcinoma in the United States. J Am Acad Dermatol. 2003;49(5):832–41.

Article  PubMed  Google Scholar 

Kukko H, Bohling T, Koljonen V, Tukiainen E, Haglund C, Pokhrel A, et al. Merkel cell carcinoma—a population-based epidemiological study in Finland with a clinical series of 181 cases. Eur J Cancer. 2012;48(5):737–42.

Article  PubMed  Google Scholar 

Mistry K, Levell NJ, Hollestein L, Wakkee M, Nijsten T, Knott CS, et al. Trends in incidence, treatment and survival of Merkel cell carcinoma in England 2004–2018: a cohort study. Br J Dermatol. 2023;188(2):228–36.

Article  PubMed  Google Scholar 

Youlden DR, Soyer HP, Youl PH, Fritschi L, Baade PD. Incidence and survival for Merkel cell carcinoma in Queensland, Australia, 1993–2010. JAMA Dermatol. 2014;150(8):864–72.

Article  PubMed  Google Scholar 

Engels EA, Frisch M, Goedert JJ, Biggar RJ, Miller RW. Merkel cell carcinoma and HIV infection. Lancet. 2002;359(9305):497–8.

Article  PubMed  Google Scholar 

Luu YT, Luo Q, Horner MJ, Shiels M, Engels EA, Sargen MR. Risk of Nonkeratinocyte skin cancers in people living with HIV during the era of antiretroviral therapy. J Investig Dermatol. 2023;143(4):588–95 (e3).

Article  CAS  PubMed  Google Scholar 

Clarke CA, Robbins HA, Tatalovich Z, Lynch CF, Pawlish KS, Finch JL, et al. Risk of Merkel cell carcinoma after solid organ transplantation. J Natl Cancer Inst. 2015;107(2):dju382.

Article  PubMed  PubMed Central  Google Scholar 

Pedersen SA, Gaist D, Schmidt SAJ, Holmich LR, Friis S, Pottegard A. Hydrochlorothiazide use and risk of nonmelanoma skin cancer: a nationwide case-control study from Denmark. J Am Acad Dermatol. 2018;78(4):673–81 (e9).

Article  CAS  PubMed  Google Scholar 

Keeling E, Murray SL, Williams Y, Sexton DJ, O’Kelly P, Deady S, et al. Merkel cell carcinoma in kidney transplant recipients in Ireland 1964–2018. Br J Dermatol. 2019;181(6):1314–5.

Article  CAS  PubMed  Google Scholar 

Eid E, Maloney NJ, Cai ZR, Zaba LC, Kibbi N, John EM, Linos E. Risk of multiple primary cancers in patients with Merkel cell carcinoma: a SEER-based analysis. JAMA Dermatol. 2023;159(11):1248–52.

Article  PubMed  Google Scholar 

Eisemann N, Jansen L, Castro FA, Chen T, Eberle A, Nennecke A, et al. Survival with nonmelanoma skin cancer in Germany. Br J Dermatol. 2016;174(4):778–85.

Article  CAS  PubMed  Google Scholar 

McEvoy AM, Hippe DS, Lachance K, Park S, Cahill K, Redman M, et al. Merkel cell carcinoma recurrence risk estimation is improved by integrating factors beyond cancer stage: a multivariable model and web-based calculator. J Am Acad Dermatol. 2023;90:569–76.

Article  PubMed  Google Scholar 

McEvoy AM, Lachance K, Hippe DS, Cahill K, Moshiri Y, Lewis CW, et al. Recurrence and mortality risk of Merkel cell carcinoma by cancer stage and time from diagnosis. JAMA Dermatol. 2022;158(4):382–9.

Article  PubMed  PubMed Central  Google Scholar 

Plummer M, de Martel C, Vignat J, Ferlay J, Bray F, Franceschi S. Global burden of cancers attributable to infections in 2012: a synthetic analysis. Lancet Glob Health. 2016;4(9):e609–16.

Article  PubMed  Google Scholar 

Basu AK. DNA damage, mutagenesis and cancer. Int J Mol Sci. 2018;19(4):970.

Article  PubMed  PubMed Central  Google Scholar 

DeGregori J. Evolved tumor suppression: why are we so good at not getting cancer? Cancer Res. 2011;71(11):3739–44.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Marongiu F, DeGregori J. The sculpting of somatic mutational landscapes by evolutionary forces and their impacts on aging-related disease. Mol Oncol. 2022;16(18):3238–58.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jacquelot N, Seillet C, Vivier E, Belz GT. Innate lymphoid cells and cancer. Nat Immunol. 2022;23(3):371–9.

Article  CAS  PubMed  Google Scholar 

Cantoni C, Huergo-Zapico L, Parodi M, Pedrazzi M, Mingari MC, Moretta A, et al. NK cells, tumor cell transition, and tumor progression in solid malignancies: new hints for NK-based immunotherapy? J Immunol Res. 2016;2016:4684268.

Article  PubMed  PubMed Central  Google Scholar 

Kabelitz D. A menage a trois of cytotoxic effector cells: gammadelta T cells suppress NK cells but not CTLs. Cancer Immunol Res. 2022;10(5):543.

Article  PubMed  Google Scholar 

Koliaraki V, Henriques A, Prados A, Kollias G. Unfolding innate mechanisms in the cancer microenvironment: the emerging role of the mesenchyme. J Exp Med. 2020. https://doi.org/10.1084/jem.20190457.

Article  PubMed  PubMed Central  Google Scholar 

Noubade R, Majri-Morrison S, Tarbell KV. Beyond cDC1: Emerging roles of DC crosstalk in cancer immunity. Front Immunol. 2019;10:1014.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Luri-Rey C, Gomis G, Glez-Vaz J, Manzanal A, Martinez Riano A, Rodriguez Ruiz ME, et al. Cytotoxicity as a form of immunogenic cell death leading to efficient tumor antigen cross-priming. Immunol Rev. 2024;321(1):143–51.

Article  CAS  PubMed  Google Scholar 

Bhattacharyya ND, Feng CG. Regulation of T helper cell fate by TCR signal strength. Front Immunol. 2020;11:624.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Apavaloaei A, Hardy MP, Thibault P, Perreault C. The origin and immune recognition of tumor-specific antigens. Cancers (Basel). 2020;12(9):2607.

Article  CAS  PubMed  Google Scholar 

Macri C, Pang ES, Patton T, O’Keeffe M. Dendritic cell subsets. Semin Cell Dev Biol. 2018;84:11–21.

Article  CAS  PubMed  Google Scholar 

Obst R. The timing of T cell priming and cycling. Front Immunol. 2015;6:563.

Article  PubMed  PubMed Central  Google Scholar 

Schumacher TN, Thommen DS. Tertiary lymphoid structures in cancer. Science. 2022;375(6576):eabf9419.

Article  CAS  PubMed  Google Scholar 

Lynch KT, Young SJ, Meneveau MO, Wages NA, Engelhard VH, Slingluff CL Jr, Mauldin IS. Heterogeneity in tertiary lymphoid structure B-cells correlates with patient survival in metastatic melanoma. J Immunother Cancer. 2021;9(6):e002273.

Article  PubMed  PubMed Central  Google Scholar 

Nakamura M, Magara T, Kano S, Matsubara A, Kato H, Morita A. Tertiary lymphoid structures and chemokine landscape in virus-positive and virus-negative Merkel cell carcinoma. Front Oncol. 2022;12: 811586.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vesely MD, Schreiber RD. Cancer immunoediting: antigens, mechanisms, and implications to cancer immunotherapy. Ann N Y Acad Sci. 2013;1284(1):1–5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu Z, Liang Q, Ren Y, Guo C, Ge X, Wang L, et al. Immunosenescence: molecular mechanisms and diseases. Signal Transduct Target Ther. 2023;8(1):200.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Paulson KG, Park SY, Vandeven NA, Lachance K, Thomas H, Chapuis AG, et al. Merkel cell carcinoma: current US incidence and projected increases based on changing demographics. J Am Acad Dermatol. 2018;78(3):457–63 (e2).

Article  PubMed  Google Scholar 

Pang C, Sharma D, Sankar T. Spontaneous regression of Merkel cell carcinoma: a case report and review of the literature. Int J Surg Case Rep. 2015;7C:104–8.

Article  CAS  PubMed